Publications by authors named "Monica Muppidi"
Tumor lysis syndrome (TLS) remains a debilitating cause of hospitalization and death in patients with cancer and is a significant challenge for healthcare providers despite advancements in its management. This umbrella review analyzed the results of meta-analyses on the use of rasburicase in the treatment of patients with cancer. A literature search was performed of five databases (PubMed, Google Scholar, Cochrane Library, Scopus, Global Index Medicus, and ScienceDirect) for articles with full texts available online.
View Article and Find Full Text PDFDrug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome is a severe cutaneous drug reaction characterized by a skin rash, eosinophilia, atypical lymphocytosis, and involvement of multiple organs. The mortality rate of DRESS syndrome is moderate, and prompt diagnosis and treatment are essential. When DRESS syndrome is presented with significant hypereosinophilia (HE), it should be differentiated from other conditions that can cause HE through a comprehensive approach to diagnostic evaluation.
View Article and Find Full Text PDFArticle Synopsis
- Job loss after a cancer diagnosis can lead to ongoing financial issues and lower treatment adherence, particularly affecting low-income and minority women who often lack access to work accommodations.
- The intervention, called TEAMWork, is a bilingual mobile app designed to support job retention by providing tailored work accommodation suggestions, negotiation coaching, symptom self-management advice, and improved communication tools for patients and medical staff.
- A randomized controlled trial will test the app against a paper booklet, focusing on the primary outcome of work status after treatment and secondary outcomes like self-efficacy in negotiating accommodations and communication with healthcare providers.*
BACKGROUND Diffuse large B cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin lymphoma (NHL). While bone marrow (BM) involvement is common in lymphoma, primary bone marrow (PBM) DLBCL is extremely rare. We present a case of PBM DLBCL discovered in a patient with COVID-19.
View Article and Find Full Text PDFIntroduction: We report our experience with cancer care delivery during the peak of COVID-19 pandemic in New York City.
Methods: Retrospective analysis of the patients treated from the 1 of March, 2020 to the 8 of May, 2020.
Results: Team huddles, infection screening and patient selection strategies were implemented.
Decitabine and Sorafenib Therapy in FLT-3 ITD-Mutant Acute Myeloid Leukemia.
Clin Lymphoma Myeloma Leuk
June 2015
Background: Acute myeloid leukemia (AML) characterized by Feline McDonough Sarcoma-like tyrosine kinase-3 (FLT-3) internal tandem duplication (ITD) mutations have poor outcomes. Treatment options are limited, because these mutations confer resistance to conventional chemotherapy. FLT-3 inhibitors such as sorafenib have been studied as a single agent and in combination with conventional chemotherapy or azacytidine with fair responses.
View Article and Find Full Text PDF